Barry Cheskin, co-founder, president, and CEO of PowerVision, introduces the company’s next iteration, Fluidvision 2020, a new IOL that doubles the power of accommodation for patients. PowerVision expects to have the IOL in clinics next year. Citing the lens’ clinical data, he also busts a myth about IOLs’ lifetime in the lens capsule.
Barry Cheskin is Co-Founder, President & CEO of PowerVision. Mr. Cheskin has over 20 years of general management experience in the medical device business.